PAK4 and neoplasm: p-Bad-microRNA axis regulates drug resistance in pancreatic ductal adenocarcinoma (PDAC), and blocking of PAK4 induces reduction of Bad phosphorylation and upregulation of tumor-suppressive miRNAs in PDAC (Mohammad et al., 2019).